期刊文献+
共找到174篇文章
< 1 2 9 >
每页显示 20 50 100
Isolated Hyperacute T-Waves in West Nile Encephalitis Indicating Atypical Variant of Stress-Induced Cardiomyopathy
1
作者 Soomal Rafique Nadeem Khan Momin Siddique 《Journal of Biosciences and Medicines》 2024年第2期303-310,共8页
Several cardiac outcomes have been reported with West Nile-encephalitis;however, the underlying pathophysiology remains complex. We present a 42-year-old female, with multiple sclerosis, whose neurological symptoms an... Several cardiac outcomes have been reported with West Nile-encephalitis;however, the underlying pathophysiology remains complex. We present a 42-year-old female, with multiple sclerosis, whose neurological symptoms and respiratory decline were finally explained by the diagnosis of West Nile-encephalitis. During her admission, the isolated peaked T-waves indicated the underlying stress-induced cardiomyopathy. The absence of all other causes of hyperacute T-waves, their subsequent resolution with the resolution of infection and improvement in wall motion abnormalities, further supported the association. This case highlights the importance of considering hyperacute T-waves in an approach towards the diagnosis of WNV-encephalitis related atypical variant of stress-induced cardiomyopathy. 展开更多
关键词 West Nile Virus encephalitis WNV Hyperacute T-Waves Takotsubo cardiomyopathy Atypical/Inverted Variant of Stress-induced cardiomyopathy CMP
下载PDF
Disease modeling of desmosome-related cardiomyopathy using induced pluripotent stem cell-derived cardiomyocytes
2
作者 Shuichiro Higo 《World Journal of Stem Cells》 SCIE 2023年第3期71-82,共12页
Cardiomyopathy is a pathological condition characterized by cardiac pump failure due to myocardial dysfunction and the major cause of advanced heart failure requiring heart transplantation.Although optimized medical t... Cardiomyopathy is a pathological condition characterized by cardiac pump failure due to myocardial dysfunction and the major cause of advanced heart failure requiring heart transplantation.Although optimized medical therapies have been developed for heart failure during the last few decades,some patients with cardiomyopathy exhibit advanced heart failure and are refractory to medical therapies.Desmosome,which is a dynamic cell-to-cell junctional component,maintains the structural integrity of heart tissues.Genetic mutations in desmo-somal genes cause arrhythmogenic cardiomyopathy(AC),a rare inheritable disease,and predispose patients to sudden cardiac death and heart failure.Recent advances in sequencing technologies have elucidated the genetic basis of cardiomyopathies and revealed that desmosome-related cardiomyopathy is concealed in broad cardiomyopathies.Among desmosomal genes,mutations in PKP2(which encodes PKP2)are most frequently identified in patients with AC.PKP2 deficiency causes various pathological cardiac phenotypes.Human cardiomyocytes differentiated from patient-derived induced pluripotent stem cells(iPSCs)in combination with genome editing,which allows the precise arrangement of the targeted genome,are powerful experimental tools for studying disease.This review summarizes the current issues associated with practical medicine for advanced heart failure and the recent advances in disease modeling using iPSC-derived cardiomyocytes targeting desmosome-related cardiomyopathy caused by PKP2 deficiency. 展开更多
关键词 cardiomyopathy Advanced heart failure induced pluripotent stem cell-derived cardiomyocytes DESMOSOME Genome editing Gene therapy
下载PDF
The Role of GPER in Sepsis-Induced Myocardial Cell Damage and 28-Day Mortality Risk
3
作者 Jiangfeng Tang Jiangqin Liu 《Yangtze Medicine》 2024年第3期57-71,共15页
Purpose: The role of GPER in sepsis-induced myocardial cell injury and its potential impact on the risk of death within 28 days in sepsis. Methods: An in vitro experiment was conducted to establish a sepsis-induced my... Purpose: The role of GPER in sepsis-induced myocardial cell injury and its potential impact on the risk of death within 28 days in sepsis. Methods: An in vitro experiment was conducted to establish a sepsis-induced myocardial cell model. H9C2 myocardial cells were treated with 10 μg/ml lipopolysaccharide (LPS) for 24 hours. The effects of different concentrations of the GPER agonist G1 (1, 3, and 10 μmol/L) on cell viability, expression of inflammatory markers, cell apoptosis, and the NF-κB pathway were evaluated. A Mendelian randomization analysis was conducted using Single Nucleotide Polymorphism (SNPs) related to the GPER gene as instrumental variables to investigate the causal relationship between the GPER gene variations and sepsis (28-day death). Results: The results indicate that the group treated with LPS showed a significant decrease in myocardial cell viability, an increase in concentrations of tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), higher apoptosis rates, and increased phosphorylation levels of NF-κB p65 (p-P65/P65) and IκB-α (p-IκB-α/IκB-α) compared to the control group (P κB pathway. However, genetic evidence did not show a causal relationship between GPER gene variations and sepsis (28-day death) (P κB pathway. However, genetic evidence did not show a causal relationship between GPER gene variations and sepsis (28-day death). 展开更多
关键词 G Protein-Coupled Estrogen Receptor Sepsis-induced cardiomyopathy Inflammation and Apoptosis Sepsis (28-Day death) Mendelian Randomization
下载PDF
Termination of polymorphic ventricular tachycardia storm by catheter ablation in a patient with cardiomyopathy induced by incessant idiopathic left ventricular tachycardia 被引量:5
4
作者 Shan, Q. J. Chen, M. L. Xu, D. X. Zou, J. G. Yang, B. Chen, C. Cao, K. J. 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2007年第10期1105-1105,共1页
关键词 室性心动过速 导管切除 心肌症 先天性疾病 左心室 治疗
下载PDF
Patient-specific induced pluripotent stem cells as“disease-in-adish”models for inherited cardiomyopathies and channelopathies–15 years of research
5
作者 Miruna Mihaela Micheu Ana-Maria Rosca 《World Journal of Stem Cells》 SCIE 2021年第4期281-303,共23页
Among inherited cardiac conditions,a special place is kept by cardiomyopathies(CMPs)and channelopathies(CNPs),which pose a substantial healthcare burden due to the complexity of the therapeutic management and cause ea... Among inherited cardiac conditions,a special place is kept by cardiomyopathies(CMPs)and channelopathies(CNPs),which pose a substantial healthcare burden due to the complexity of the therapeutic management and cause early mortality.Like other inherited cardiac conditions,genetic CMPs and CNPs exhibit incomplete penetrance and variable expressivity even within carriers of the same pathogenic deoxyribonucleic acid variant,challenging our understanding of the underlying pathogenic mechanisms.Until recently,the lack of accurate physiological preclinical models hindered the investigation of fundamental cellular and molecular mechanisms.The advent of induced pluripotent stem cell(iPSC)technology,along with advances in gene editing,offered unprecedented opportunities to explore hereditary CMPs and CNPs.Hallmark features of iPSCs include the ability to differentiate into unlimited numbers of cells from any of the three germ layers,genetic identity with the subject from whom they were derived,and ease of gene editing,all of which were used to generate“disease-in-a-dish”models of monogenic cardiac conditions.Functionally,iPSC-derived cardiomyocytes that faithfully recapitulate the patient-specific phenotype,allowed the study of disease mechanisms in an individual-/allele-specific manner,as well as the customization of therapeutic regimen.This review provides a synopsis of the most important iPSC-based models of CMPs and CNPs and the potential use for modeling disease mechanisms,personalized therapy and deoxyribonucleic acid variant functional annotation. 展开更多
关键词 induced pluripotent stem cells cardiomyopathy CHANNELOPATHY Genes Mutation Deoxyribonucleic acid variants
下载PDF
Alcohol-Induced Cardiomyopathy Presenting with Left Ventricular Apical Thrombus
6
作者 Farid Khan Casey Manzanero +1 位作者 Amit Bansal Sreekanth Kondareddy 《World Journal of Cardiovascular Diseases》 CAS 2022年第7期353-359,共7页
Background: Chronic excessive alcohol consumption has been strongly associated with alcohol-induced cardiomyopathy (AC) in patients with no evidence of coronary artery disease (CAD). AC may cause cardiovascular c... Background: Chronic excessive alcohol consumption has been strongly associated with alcohol-induced cardiomyopathy (AC) in patients with no evidence of coronary artery disease (CAD). AC may cause cardiovascular complications and significant impact on the quality of life. We discuss an interesting case of dilated cardiomyopathy, associated complication, diagnostic work-up and management. Case Report: A young male presented to our service with worsening dyspnea, orthopnea, and scrotal and lower extremity edema. On average, he consumed a pack of 12 beers every day and had a 30-pack-years smoking history. He was found to be in acute heart failure with evidence of pulmonary edema and cardiomegaly on chest imaging. He had biventricular dilatation and severely reduced left ventricular ejection fraction (LVEF) 15% in addition to a thrombus in the LV apex. The cardiac catheterization was unremarkable for CAD. He was diuresed appropriately resulting in significant weight loss and resolution of symptoms. LV thrombus was treated with unfractionated heparin infusion that was transitioned to warfarin. He was maintained on guidelines-directed medical therapy for heart failure. Extensive counseling was provided regarding alcohol and tobacco cessation. On follow-up echocardiogram, his LVEF improved and there was no evidence of LV thrombus. We think, the readership will benefit from our experience of treating a case of AC, and the importance of clinical history. Conclusion: Chronic excessive alcohol use is detrimental to cardiac function leading to alcohol-induced cardiomyopathy. A careful approach to clinical history of alcohol consumption and prompt diagnostic workup negative for ischemic causes may confirm the diagnosis. Cardiac function improves with guidelines-directed medical therapy for heart failure and abstinence from alcohol. 展开更多
关键词 Alcohol-induced cardiomyopathy Heart Failure Echocardiography THROMBUS DIURESIS
下载PDF
Improvement of left ventricular function in patients with persistent atrial tachyarrhythmia induced cardiomyopathy undergoing radiofrequency ablation
7
作者 Xiangmin Shi Zhaoliang Shan +1 位作者 Hongyang Guo Yutang Wang 《World Journal of Cardiovascular Diseases》 2013年第9期529-535,共7页
Purpose: To investigate the alteration of left ventricular function in subjects with persistent atrial tachyarrhythmia induced cardiomyopathy (TIC) undergoing radiofrequency ablation, and to study the pathogenesis and... Purpose: To investigate the alteration of left ventricular function in subjects with persistent atrial tachyarrhythmia induced cardiomyopathy (TIC) undergoing radiofrequency ablation, and to study the pathogenesis and effective treatment of TIC. Methods: A total of 25 cases with persistent atrial tachyarrhythmia and impaired left ventricular systolic function were studied (16 men and 9 women, aged 53.3 ± 15.2 years), and all subjects underwent electrophysiological study and radiofrequency ablation of atrial tachyarrhythmia under the guidance of CARTO system during 2006.9-2011.8. Indexes related to cardiac function, including left ventricular end diastolic diameter (LVEDD), left ventricular ejection fraction (LVEF), New York Heart Association functional classification (NYHA class), 6 minutes walking test (6MWT), N-terminal pro-brain natriuretic peptide (BNP) and 24 hours average heart rate (AHR), were analyzed at the time point of 7 days, 3 and 6 months after the procedure as well as 1 day before ablation. Results: No refractory atrial arrhythmia recurred in all cases after ablation, compared with LVEDD (51.7 ± 4.5 mm), LVEF (39.0% ± 4.3%), number of patients with NYHA class IV and III (n = 17), 6MWT (212 ± 56 m), BNP (3622 ± 1860 ng/L) and AHR (112.5 ± 23.2 bpm) before ablation, the index of LVEDD (45.2 ± 3.3 mm;41.7 ± 2.5 mm;40.5 ± 3.1 m), BNP (2429 ± 1355 ng/L;1530 ± 866 ng/L;1300 ± 520 ng/L), total number of patients of NYHA class IV and III (n = 11;3;2) and AHR (73.3 ± 15.3 bpm;68.7 ± 13.5 bpm;66.3 ± 13.6 bpm) significantly decreased (P < 0.05), LVEF (45.6 ± 3.5%;51.5 ± 2.7%;53.5 ± 3.1%) and 6MWT (262 ± 47 m;305 ± 37 m;313 ± 41 m) greatly increased (P < 0.05)in 7 days, 3 and 6 months after ablation respectively. There was a statistical difference between 7 days and 3 or 6 months after ablation in above-mentioned indexes (P < 0.05) except AHR (P > 0.05), no significant difference existed between 3 and 6 months in all indexes (P > 0.05). Conclusion: long-lasting atrial arrhythmia with rapid ventricular response could impair left ventricle function, which could be reversed within weeks after successful ablation and restoration of sinus rhythm. 展开更多
关键词 Tachyarrhythmia-induced cardiomyopathy RADIOFREQUENCY Ablation Left VENTRICULAR Dysfunction SINUS RHYTHM
下载PDF
Cardiac disease modeling using induced pluripotent stem cell-derived human cardiomyocytes 被引量:1
8
作者 Patrizia Dell'Era Patrizia Benzoni +4 位作者 Elisabetta Crescini Matteo Valle Er Xia Antonella Consiglio Maurizio Memo 《World Journal of Stem Cells》 SCIE CAS 2015年第2期329-342,共14页
Causative mutations and variants associated with cardiac diseases have been found in genes encoding cardiac ion channels, accessory proteins, cytoskeletal components, junctional proteins, and signaling molecules. In m... Causative mutations and variants associated with cardiac diseases have been found in genes encoding cardiac ion channels, accessory proteins, cytoskeletal components, junctional proteins, and signaling molecules. In most cases the functional evaluation of the genetic alterationhas been carried out by expressing the mutated proteins in in-vitro heterologous systems. While these studies have provided a wealth of functional details that have greatly enhanced the understanding of the pathological mechanisms, it has always been clear that heterologous expression of the mutant protein bears the intrinsic limitation of the lack of a proper intracellular environment and the lack of pathological remodeling. The results obtained from the application of the next generation sequencing technique to patients suffering from cardiac diseases have identified several loci, mostly in non-coding DNA regions, which still await functional analysis. The isolation and culture of human embryonic stem cells has initially provided a constant source of cells from which cardiomyocytes(CMs) can be obtained by differentiation. Furthermore, the possibility to reprogram cellular fate to a pluripotent state, has opened this process to the study of genetic diseases. Thus induced pluripotent stem cells(i PSCs) represent a completely new cellular model that overcomes the limitations of heterologous studies. Importantly, due to the possibility to keep spontaneously beating CMs in culture for several months, during which they show a certain degree of maturation/aging, this approach will also provide a system in which to address the effect of long-term expression of the mutated proteins or any other DNA mutation, in terms of electrophysiological remodeling. Moreover, since i PSC preserve the entire patients' genetic context, the system will help the physicians in identifying the most appropriate pharmacological intervention to correct the functional alteration. This article summarizes the current knowledge of cardiac genetic diseases modelled with i PSC. 展开更多
关键词 CARDIOMYOPATHIES Cardiac ARRHYTHMIAS induced PLURIPOTENT stem cells Human CARDIOMYOCYTES
下载PDF
参附注射液联合血必净注射液对脓毒症心肌病患者循环和毛细血管充盈时间的影响 被引量:1
9
作者 袁文超 陈仁山 李小悦 《遵义医科大学学报》 2024年第1期70-75,共6页
目的 评价参附注射液加血必净注射液对(脓毒症心肌病SIC)患者循环和毛细血管充盈时间的影响。方法 将87例SIC患者随机分为治疗组和对照组,对照组44例,治疗组43例。对照组患者给予脓毒症集束化治疗;治疗组在对照组的基础上给予血必净注... 目的 评价参附注射液加血必净注射液对(脓毒症心肌病SIC)患者循环和毛细血管充盈时间的影响。方法 将87例SIC患者随机分为治疗组和对照组,对照组44例,治疗组43例。对照组患者给予脓毒症集束化治疗;治疗组在对照组的基础上给予血必净注射液加参附注射液静脉滴注,两组疗程均为3 d。评估病情和预后指标(APACHEⅡ评分、SOFA评分)、心肌损伤标志物(cTnT、NT-ProBNP)、血流动力学指标(MAP、CVP、CI)、微循环指标(Lac、24 h Lac清除率、CRT)。结果 治疗后,两组APACHEⅡ评分、SOFA评分、cTnT、NT-ProBNP、Lac、CRT均降低(P<0.05),均以治疗组更明显(P<0.05),24 h Lac清除率治疗组高于对照组(P<0.05)。治疗后两组患者MAP、CVP较治疗前均升高,治疗后24、48、72 h,治疗组CI高于照组;治疗后第6、24 h,治疗组患者Lac低于对照组(P<0.05);治疗后第3、6、24 h,治疗组患者CRT低于对照组(P<0.05)。结论 在西医常规集束化治疗的基础上,加用参附注射液和血必净注射液治疗,可改善微循环及血流动力学,抑制心肌损伤,有利于改善SIC患者的心功能。 展开更多
关键词 脓毒症心肌病 毛细血管再充盈时间 血必净注射液 参附注射液
下载PDF
儿童脓毒性心肌病的临床特征及发病危险因素分析
10
作者 郭恩玉 房艳岭 +4 位作者 耿化晓 王文杰 李姗姗 孟祥兰 张海防 《新医学》 CAS 2024年第5期348-353,共6页
目的探讨脓毒症儿童合并脓毒性心肌病(SICM)的临床特征及发病危险因素,为提高临床医师的诊治水平提供参考。方法回顾性分析脓毒症患儿的临床资料。按照是否发生SICM,将其分为SICM组和非SICM组,比较2组患儿的临床特点及转归,分析SICM发... 目的探讨脓毒症儿童合并脓毒性心肌病(SICM)的临床特征及发病危险因素,为提高临床医师的诊治水平提供参考。方法回顾性分析脓毒症患儿的临床资料。按照是否发生SICM,将其分为SICM组和非SICM组,比较2组患儿的临床特点及转归,分析SICM发生的危险因素。结果(1)398例脓毒症患儿被纳入研究,其SICM发病率为15.58%(62/398)。SICM组年龄[49(18,108)个月]大于非SICM组[19(6,52)个月],SICM组合并脓毒性休克比例[83.87%(52/62)]高于非SICM组[42.56%(143/336)];SICM组病死率[29.03%(18/62)]高于非SICM组[14.58%(49/336)],比较差异均有统计学意义(P<0.05)。(2)多因素Logistic回归分析显示:年长儿发生SICM的风险更高(OR=1.010,95%CI 1.003~1.017,P=0.006);血乳酸水平越高,发生SICM的风险越高(OR=1.163,95%CI 1.034~1.308,P=0.012);肌钙蛋白水平越高,发生SICM风险越高(OR=9.929,95%CI 4.651~21.197,P<0.001)。结论与非SICM患儿相比,SICM患儿更易发生脓毒性休克,病死率更高。年龄、乳酸及cTnI为儿童SICM独立的影响因素。 展开更多
关键词 儿童 脓毒症 脓毒性心肌病 危险因素 临床特征 脓毒性休克
下载PDF
脓毒性心肌病“虚气流滞”中医病机及“炎症-线粒体损伤”恶性循环假说
11
作者 黄坡 方晓磊 刘清泉 《中国中医急症》 2024年第7期1183-1185,共3页
脓毒性心肌病是脓毒症引起的急性可逆性心功能障碍,病理机制复杂。本研究在王永炎院士创新性提出“虚气流滞”病机理论的影响下,剖析了脓毒性心肌病“虚气流滞”病机,同时基于现代研究成果总结脓毒性心肌病“炎症-线粒体损伤”恶性循环... 脓毒性心肌病是脓毒症引起的急性可逆性心功能障碍,病理机制复杂。本研究在王永炎院士创新性提出“虚气流滞”病机理论的影响下,剖析了脓毒性心肌病“虚气流滞”病机,同时基于现代研究成果总结脓毒性心肌病“炎症-线粒体损伤”恶性循环假说,从宏观和微观两个层面上构建了中西医研究脓毒性心肌病的重要汇合点。“虚气流滞”病机和“炎症-线粒体损伤”的恶性循环假说的契合打开了脓毒性心肌病研究的新视角。 展开更多
关键词 脓毒性心肌病 虚气流滞 炎症 线粒体 病机
下载PDF
氧化苦参碱对高糖诱导乳鼠原代心肌成纤维细胞转分化的作用及机制
12
作者 张宇菲 罗红 +3 位作者 肖红 陶玲 沈祥春 常楚瑞 《贵州医科大学学报》 CAS 2024年第3期329-339,共11页
目的探讨氧化苦参碱(OMT)对高糖(HG)诱导乳鼠原代心肌成纤维细胞(CFBs)增殖和转分化的作用及机制。方法Sprague-Dawley(SD)乳鼠20只,取乳鼠心脏的心尖部分分离与培养原代CFBs,取对数生长期CFBs细胞分为空白(Control)组、40 mmol/L甘露醇... 目的探讨氧化苦参碱(OMT)对高糖(HG)诱导乳鼠原代心肌成纤维细胞(CFBs)增殖和转分化的作用及机制。方法Sprague-Dawley(SD)乳鼠20只,取乳鼠心脏的心尖部分分离与培养原代CFBs,取对数生长期CFBs细胞分为空白(Control)组、40 mmol/L甘露醇(Mannitol)组、不同浓度(30、35、40、45及50 mmol/L)HG组及不同浓度(25、50、100、200、400 mg/L)OMT组,采用噻唑蓝比色法(MTT)法检测细胞的增殖情况并确定后续实验OMT的保护浓度;按前述OMT的保护浓度结果,取对数生长期CFBs细胞分为空白(Control)组、40 mmol/L甘露醇(Mannitol)组、40 mmol/L HG(HG)组、40 mmol/L HG+50 mg/L OMT(OMT低剂量)组、40 mmol/L HG+100 mg/L OMT(OMT中剂量)组及40 mmol/LHG+200 mg/L OMT(OMT高剂量)组,采用天狼星红和苏木素-伊红(HE)染色法观察各组细胞的胶原纤维表达及形态变化,采用羟脯氨酸(Hyp)试剂盒检测法和免疫荧光染色法检测各组细胞Hyp及α-平滑肌肌动蛋白(α-SMA)的表达,采用流式细胞术检测各组细胞的周期分布比例,采用Western blot检测CFBs中α-SMA、结缔组织生长因子(CTGF)、Ⅰ型胶原(CollagenⅠ)、Ⅲ型胶原(CollagenⅢ)、血管内皮生长因子A(VEGFA)及缺氧诱导因子-1α(HIF-1α)蛋白的表达。结果与HG组相比,50、100及200 mg/L OMT组CFBs细胞活力下降(P<0.05);与HG组相比,50、100及200 mg/L OMT组CFBs细胞形态发生变化,细胞数量变少;与HG组相比,50、100及200 mg/L OMT组CFBs内Hyp含量减少,细胞在S期分布比例降低(P<0.05);与Control组相比,HG组CFBs细胞数量增多,α-SMA表达增多;与HG组相比,50、100及200 mg/L OMT组CFBs细胞数量减少,α-SMA表达减少;与HG组相比,50、100及200 mg/L OMT组HIF-1α、VEGFA、α-SMA、CTGF、CollagenⅠ、CollagenⅢ及FN表达下调(P<0.05)。结论OMT可抑制乳鼠CFBs增殖并诱导细胞转分化,其机制可能与调节HIF-1α信号相关。 展开更多
关键词 细胞增殖 糖尿病心肌病 缺氧诱导因子-1α 乳鼠 氧化苦参碱 高糖 心肌成纤维细胞 转分化
下载PDF
基于CiteSpace的脓毒症心肌病研究动态及热点知识图谱分析
13
作者 盛松 张艳虹 +2 位作者 高洪阳 王幸 黄烨 《中西医结合心脑血管病杂志》 2024年第3期410-416,451,共8页
目的:基于CiteSpace知识图谱探讨近10年脓毒症心肌病(SICM)的研究现状和研究热点。方法:通过Web of Science检索2012—2022年6月SICM相关文献,应用文献计量学研究方法和CiteSpace软件对SICM文献的产出数量、国家/地区、研究机构、发文... 目的:基于CiteSpace知识图谱探讨近10年脓毒症心肌病(SICM)的研究现状和研究热点。方法:通过Web of Science检索2012—2022年6月SICM相关文献,应用文献计量学研究方法和CiteSpace软件对SICM文献的产出数量、国家/地区、研究机构、发文作者和共被引作者及双图叠加共被引期刊网络、关键词时间线网络和共被引文献网络进行文献计量学分析和可视化展示,探讨SICM研究现状和研究热点。结果:共纳入3814篇文献,近10年SICM相关文献逐年增长,2016年开始文献产出激增。从国家/地区、研究机构和作者发文频次角度,中国与欧美国家齐头并进,但是从论文影响力和共被引作者角度看,我国与欧美国家仍差距明显。近2年和近10年期刊共被引频次排名前10位的杂志相同,包括Crit Care Med、Crit Care等。SICM研究热点包括急性肾损伤、脓毒症心肌损伤、脓毒症休克、心源性休克、心肌梗死,涉及SICM的病因、病理机制、评估、治疗、并发症和预后。频次排名前10位的高被引文献主要为脓毒症的指南共识和随机对照试验及SICM研究综述。结论:基于CiteSpace对SICM文献进行计量学分析,可以更加清晰、直观地了解到全球SICM的研究现状,有助于总结该领域的研究现状,推动该领域的发展。 展开更多
关键词 脓毒症心肌病 CITESPACE 知识图谱 文献计量学分析
下载PDF
肠道微生物群与脓毒症心肌病相互作用的研究进展
14
作者 牟青松 任香凝 +1 位作者 陆金帅 张静 《中国现代医学杂志》 CAS 2024年第19期51-55,共5页
脓毒症心肌病(SICM)是脓毒症的常见并发症,其发病机制尚不完全清楚。目前大量研究证明肠道微生态与多种心血管疾病相关,而少有研究报道肠道菌群对SICM的影响。近年来,有研究发现,除了已知的机制外,肠道微生物组失衡、黏膜屏障损伤、微... 脓毒症心肌病(SICM)是脓毒症的常见并发症,其发病机制尚不完全清楚。目前大量研究证明肠道微生态与多种心血管疾病相关,而少有研究报道肠道菌群对SICM的影响。近年来,有研究发现,除了已知的机制外,肠道微生物组失衡、黏膜屏障损伤、微生物易位、代谢失调、线粒体功能障碍及炎症反应可能通过肠-心轴或肠-肾-心轴影响SICM。该综述主要探讨了脓毒症期间肠道菌群与SICM的潜在联系,更好地了解这一机制将有助于改善脓毒症的治疗,并使脓毒症患者获得更好的预后。 展开更多
关键词 脓毒症 脓毒症心肌病 肠道菌群 微生物-肠-心轴
下载PDF
应激性心肌病的研究进展
15
作者 唐琛 史宏志 +4 位作者 韩红亚 刘晓丽 赵亦骢 王琛茜 张佳宜 《心血管病学进展》 CAS 2024年第7期593-597,共5页
应激性心肌病是以可逆性室壁运动异常为特征的一种心血管综合征,临床表现与急性冠脉综合征相似,但冠状动脉造影显示冠状动脉解剖正常。应激性心肌病的发病机制尚未完全明确,临床诊断不易,标准治疗药物存在争议,因并发症和复发风险导致... 应激性心肌病是以可逆性室壁运动异常为特征的一种心血管综合征,临床表现与急性冠脉综合征相似,但冠状动脉造影显示冠状动脉解剖正常。应激性心肌病的发病机制尚未完全明确,临床诊断不易,标准治疗药物存在争议,因并发症和复发风险导致预后不佳。现总结应激性心肌病的流行病学、发病机制、诊断和治疗方面的最新进展,以期为改善疾病的预后提供思路。 展开更多
关键词 应激性心肌病 儿茶酚胺 嗜铬细胞瘤 Β肾上腺素受体阻滞剂
下载PDF
β1受体阻滞剂防治脓毒症心肌病作用的研究进展
16
作者 胡盛惠 姚立影 +1 位作者 魏薇 高岩 《中国临床新医学》 2024年第2期227-232,共6页
脓毒症心肌病是脓毒症引起的可逆性心肌损伤,是一种非缺血性急性心功能障碍,可显著增加脓毒症患者的病死率。β1受体阻滞剂具有抗应激、抗氧化、调节免疫和抑制细胞死亡及保护心肌的作用。该文对β1受体阻滞剂防治脓毒症心肌病作用的研... 脓毒症心肌病是脓毒症引起的可逆性心肌损伤,是一种非缺血性急性心功能障碍,可显著增加脓毒症患者的病死率。β1受体阻滞剂具有抗应激、抗氧化、调节免疫和抑制细胞死亡及保护心肌的作用。该文对β1受体阻滞剂防治脓毒症心肌病作用的研究进展作一综述。 展开更多
关键词 脓毒症 脓毒症心肌病 Β1受体阻滞剂 艾司洛尔 药理作用
下载PDF
铁死亡在阿霉素心肌病中的作用机制
17
作者 宋自崇 王静艺 张黎军 《心血管病学进展》 CAS 2024年第4期307-311,共5页
阿霉素是目前应用最广泛的抗肿瘤药,但其心脏毒性限制了临床疗效。阿霉素可引起心肌细胞损伤、心脏进行性扩大和不可逆的心肌损伤,最终导致扩张型心肌病及充血性心力衰竭,称为阿霉素心肌病(DIC)。DIC的发病机制包括钙处理异常、氧化应... 阿霉素是目前应用最广泛的抗肿瘤药,但其心脏毒性限制了临床疗效。阿霉素可引起心肌细胞损伤、心脏进行性扩大和不可逆的心肌损伤,最终导致扩张型心肌病及充血性心力衰竭,称为阿霉素心肌病(DIC)。DIC的发病机制包括钙处理异常、氧化应激、线粒体破坏、凋亡和自噬等。近期多项研究报道了一种新的调节性细胞死亡——铁死亡参与其发病。现描述铁死亡的主要机制,并总结铁超载、PRMT4、Sirt1/Nrf2/Keap1通路、FUNDC2、METTL14介导的铁死亡在DIC中的作用机制,旨在对DIC病理生理机制有进一步的认识,为DIC治疗及预防提供新的潜在有效靶点。 展开更多
关键词 铁死亡 阿霉素心肌病 机制
下载PDF
特发性室性期前收缩评估和管理的研究进展
18
作者 杨扬 李梦梦 +1 位作者 韩康宁 龙德勇 《中国医药》 2024年第4期610-613,共4页
特发性室性期前收缩是临床常见的心律失常类型,既往观点认为此类疾病多数预后良好。但近年来人们发现这一过去被普遍认为是良性、无需过多干预的心脏节律异常,与部分患者左心室功能可逆性减退,甚至发生心力衰竭相关,并由此引出室性期前... 特发性室性期前收缩是临床常见的心律失常类型,既往观点认为此类疾病多数预后良好。但近年来人们发现这一过去被普遍认为是良性、无需过多干预的心脏节律异常,与部分患者左心室功能可逆性减退,甚至发生心力衰竭相关,并由此引出室性期前收缩诱发性心肌病这一概念。并非所有室性期前收缩最终都会进展为心肌病,这一过程受室性期前收缩负荷、起源部位、QRS波群时程、伴随症状等多因素的共同影响。成功的导管消融术和抗心律失常药物治疗能够有效减少患者室性期前收缩负荷,改善甚至逆转已经受损的心功能。 展开更多
关键词 特发性室性期前收缩 室性期前收缩诱发性心肌病 室性期前收缩负荷
下载PDF
美托洛尔联合射频消融对儿童心律失常性心肌病的疗效 被引量:1
19
作者 郭雨 陈金花 谭晓敏 《中国药物应用与监测》 CAS 2024年第2期148-152,共5页
目的探究美托洛尔联合射频消融治疗儿童心律失常性心肌病(AIC)的效果。方法选取我院2021年1月—2022年1月收治的AIC患儿并按随机数字表法分为对照组(射频消融治疗)和观察组(美托洛尔联合射频消融),各47例,比较两组患儿疗效和不良反应。... 目的探究美托洛尔联合射频消融治疗儿童心律失常性心肌病(AIC)的效果。方法选取我院2021年1月—2022年1月收治的AIC患儿并按随机数字表法分为对照组(射频消融治疗)和观察组(美托洛尔联合射频消融),各47例,比较两组患儿疗效和不良反应。结果治疗后,对照组和观察组左室舒张末径(LVEDD)值分别为2.60 mm和1.70 mm,平均心率、最快心率分别为(113.61±20.13)次·min-1和(101.22±18.72)次·min-1、(151.75±27.63)次·min-1和(135.22±25.24)次·min-1,脑钠肽(BNP)升高率和肌钙蛋白Ⅰ(cTnI)升高率分别为44.68%和12.76%、23.40%和10.63%,肌酸激酶同工酶(CK-MB)和红细胞沉降率(ESR)水平分别为(5.16±0.96)ng·mL^(-1)和(3.10±1.01)ng·mL^(-1)、(11.63±3.96)mm·h-1和(6.12±2.25)mm·h-1,均较治疗前降低(P<0.05);对照组和观察组左室射血分数(LVEF)和左室缩短分数(LVFS)值分别为(55.89±5.82)%和(64.33±6.11)%、29.42%和32.63%,较治疗前升高,且观察组指标优于对照组(P<0.05)。观察组不良反应发生率(4.25%)和对照组(6.38%)比较差异无统计学意义(P>0.05);治疗后1、2年,观察组有效率(78.71%和91.84%)高于对照组(57.44%和74.46%),再入院率(4.25%和6.38%)低于对照组(23.40%和31.91%),差异有统计学意义(P<0.05)。结论射频消融联合美托洛尔治疗儿童AIV的疗效显著,安全性高。 展开更多
关键词 心律失常性心肌病 射频消融治疗 美托洛尔 疗效 安全性
下载PDF
左心室整体纵向应变和左室射血分数对脓毒性心肌病病人预后的预测价值
20
作者 邱黎菲 江利东 姜远普 《中西医结合心脑血管病杂志》 2024年第21期3984-3988,共5页
目的:观察左心室整体纵向应变(LVGLS)和左室射血分数(LVEF)对脓毒性心肌病(SIC)病人预后的预测价值。方法:回顾性选取2022年9月—2023年12月我院收治的108例SIC病人临床资料,根据28 d存活情况将其分为生存组与病死组,比较两组病人临床... 目的:观察左心室整体纵向应变(LVGLS)和左室射血分数(LVEF)对脓毒性心肌病(SIC)病人预后的预测价值。方法:回顾性选取2022年9月—2023年12月我院收治的108例SIC病人临床资料,根据28 d存活情况将其分为生存组与病死组,比较两组病人临床资料、入院时左心室应变参数与心功能指标,采用多因素Logistic回归分析SIC病人预后水平的影响因素,并采用受试者工作特征(ROC)曲线分析LVGLS、LVEF对SIC病人预后的预测价值。结果:108例SIC病人中,随访28 d共35例病人死亡,纳入病死组,剩余73例纳入生存组。病死组病人入院24 h内的急性生理学与慢性健康状况评分Ⅱ(APACHEⅡ)、序贯器官衰竭评分(SOFA)、肌钙蛋白I(cTnI)及血乳酸(Lac)水平均高于生存组(P<0.05),LVGLS绝对值、整体径向应变(GRS)绝对值及LVEF均低于生存组(P<0.05),且多因素Logistic回归分析显示,APACHEⅡ评分、cTnI、Lac、LVGLS及LVEF是SIC病人预后的独立影响因素(P<0.05)。ROC特征曲线结果显示,LVGLS预测SIC病人预后水平的最佳截断值为-12.33%,LVEF最佳截断值为29.43%,且LVGLS联合LVEF预测SIC病人预后的曲线下面积(AUC)及敏感度均高于单一指标预测(P<0.05)。结论:入院时APACHEⅡ评分、cTnI、Lac、LVGLS及LVEF水平均为SIC病人预后的独立影响因素,且LVGLS联合LVEF对SIC病人预后具有较高的预测价值,可作为预后评估的主要临床指标,建议予以重点关注。 展开更多
关键词 脓毒性心肌病 左心室整体纵向应变 左室射血分数 预后 预测价值
下载PDF
上一页 1 2 9 下一页 到第
使用帮助 返回顶部